Aion Therapeutic Inc.
OTC: ANTCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- John Graham Simmonds Jr.
- Employees
- 5
- Headquarters
- Vancouver, Canada
- IPO year
- 2021
- Market cap
- $2.1M
- Website
- https://www.aiontherapeutic.com
Loading ANTCF…
Loading profile data…Frequently asked questions about ANTCF
What does Aion Therapeutic Inc. (ANTCF) do?
Aion Therapeutic Inc. operates within Canada, focusing on the provision of medicinal cannabis products. The company, which commenced operations in 2011, adopted its current name, Aion Therapeutic Inc., in August 2020, having previously been known as Osoyoos Cannabis Inc. Its main administrative base is located in Toronto, Canada.
Where does ANTCF trade?
Aion Therapeutic Inc. (ANTCF) trades on the Other OTC.
What sector is ANTCF in?
Aion Therapeutic Inc. (ANTCF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Aion Therapeutic Inc.?
John Graham Simmonds Jr. is the chief executive officer of Aion Therapeutic Inc. (ANTCF).
Where is Aion Therapeutic Inc. headquartered?
Aion Therapeutic Inc. is headquartered in Canada.
Does ANTCF pay a dividend?
Aion Therapeutic Inc. (ANTCF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ANTCF go public?
Aion Therapeutic Inc. (ANTCF) completed its initial public offering in 2021.